Table 5 Significant genetic risk factors for atorvastatin associated muscle symptoms adjusted for the non-genetic covariates.
Variable | OR crude (95% CI)a | p valuea | OR adjusted (95% CI)b | p valueb |
|---|---|---|---|---|
TT vs. CT + CC 1236C > T | 3.155 (1.178–8.868) | 0.0240 | 4.292 (1.481–13.69) | 0.0093 |
T(A)/T(A) vs. GT(A) + GG 2677G > T/A | 5.943 (2.03–20.01) | 0.0019 | 5.897 (1.975–20.06) | 0.0023 |
TT vs. CT + CC 3435C > T | 3.457 (1.352–9.25) | 0.0107 | 3.547 (1.342–9.908) | 0.0122 |
TTT/TTT vs. others | 7.097 (2.009–33.33) | 0.0047 | 9.234 (2.399–47.84) | 0.0028 |